RSS-Feed abonnieren
DOI: 10.1055/s-2004-829185
Synthesis of Saturated Imidazolidin[1,5-a]- and Thiazolidin[3,4-a]perhydroquinoxalin-4-one and Imidazolidin[1,5-a]piperazin-4-one Derivatives. Ring Contraction of Perhydroquinoxalin-4-one to Perhydrobenzimidazolin-2-one
Publikationsverlauf
Publikationsdatum:
30. Juli 2004 (online)
Abstract
Saturated fused systems such as imidazolidin[1,5-a]- and thiazolidin[3,4-a]perhydroquinoxalin-4-one as well as imidazolidin[1,5-a]piperazin-4-one derivatives were prepared by cyclocondensation reactions of appropriate perhydroquinoxalin-3-one and piperazin-3-one derivatives with diiodomethane and thiophosgene. An unusual ring contraction of perhydroquinoxalin-3-one derivatives to perhydrobenzimidazolidin-2-one derivatives by reaction with 1,2-dibromoethane was proved using crystal structure analysis with synchrotron and laboratory radiation sources.
Key words
imidazolidin[1,5-a]perhydroquinoxaline - thiazolidin[3,4-a]perhydroquinoxaline - imidazolidin[1,5-a]piperazine - fused saturated hetorocycles
- 1
Hansen HC, andWatjen F. inventors; S. African ZA 8904430. ; Chem. Abstr. 1990, 113, 212016 - 2
Hansen HC. inventors; PCT Int. Appl. WO 9200298. ; Chem. Abstr. 1992, 116, 174168 - 3
Tenbrink RE,Jacobsen EJ, andGammill RB. inventors; PCT Int. Appl. WO 9222552. ; Chem. Abstr. 1993, 119, 72624 - 4
Watjen F, andHansen HC. inventors; Eur. Pat. Appl. EP 368652. ; Chem. Abstr. 1990, 113, 172052 - 5
Hansen HC, andWatjen F. inventors; Eur. Pat. Appl. EP 347094. ; Chem. Abstr. 1990, 113, 115337 - 6
Watjen F, andHansen HC. inventors; PCT Int. Appl. WO 9107407. ; Chem.Abstr. 1991, 115, 114549 - 7
Tenbrink RE,Jacobsen EJ, andGammill RB. inventors; US Patent 5541324. ; Chem. Abstr. 1996, 125, 195687 - 8
Jacobsen EJ.Stelzer LS.Tenbrink RE.Belonga L.Carter DB.Im HK.Im WB.Sethy VH.Tang AH.VonVoigtländer PF.Petke JD.Zhong W.-Z.Mickelson JW. J. Med. Chem. 1999, 42: 1123 - 9
Jacobsen EJ.Stelzer LS.Belonga KL.Carter B.Im WB.Sethy VH.Tang AH.VonVoigtländer PF.Petke JD. J. Med. Chem. 1996, 39: 3820 - 10
Lee TDY, andBrown RE. inventors; Eur. Pat. Appl. EP 70518. ; Chem. Abstr. 1983, 99, 22496 - 11
Davey DD. inventors; Eur. Pat. Appl. EP 400583. ; Chem. Abstr. 1991, 114, 185550 - 12
Lee TD, andBrown RE. inventors; US Patent 4440929. ; Chem. Abstr. 1984, 101, 7202 - 13
Ager IR.Barnes AC.Danswan GW.Hairsine PW.Kay DP.Kennewell PD.Matharu SS.Miller P.Robson P.Rowlands DA.Tully WR.Westwood R. J. Med. Chem. 1988, 31: 1098 - 14
Taguchi M,Kondo H, andSakamoto F. inventors; Jpn. Kokai Tokkyo Koho JP 04120081. ; Chem. Abstr. 1992, 117, 212523 - 15
Zaleska B.Bazanek T.Socha R.Karelus M.Grochowski J.Serda P. J. Org. Chem. 2002, 67: 4526 - 16
Zaleska B.Karelus M. Synlett 2002, 1831 - 17
Zaleska B.Socha R.Karelus M.Szneler E.Grochowski J.Serda P. J. Org. Chem. 2003, 68: 2334
References
Compound 8 with formula C18H23N3OS crystallizes in the monoclinic system, space group P21/n, with unit cell parameters a = 1086.70(2), b = 722.07(1), c = 2201.27 (3) pm, β = 91.748(1)º, V = 1.72647(5) × 109 pm3, Z = 4. A total of 14964 reflections were collected and merged to give 3957 independent reflections (R(int) = 0.0274) on a single-crystal sample (size 0.35 × 0.2 × 0.15 mm) using a KappaCCD diffractometer and MoKα radiation. The structure was solved by direct methods and refined by the full-matrix least squares method on F2 using the SHELX97 program system. All hydrogen atoms were located on a difference Fourier map of electron density. Final R indices for I>2σ(I) were equal to R1 = 0.0441, wR2 = 0.1105, and R1 = 0.0604, w R2 = 0.1210 for all data. The final difference Fourier map of electron density was featureless with the largest peak and hole at 2.38 × 10-7 and -3.29 × 10-7 e.pm-3, respectively. The structural data have been deposited at the Cambridge Crystallographic Data Centre under the reference number CCDC 239169.